Budesonide
Ciclesonide
Fluticasone Propionate
Fluticasone Furoate
Mometasone Furoate (Anhydrous and Monohydrate)
Formoterol Fumarate Dihydrate (hemifumarate)
Salmeterol Xinafoate
Salbutamol Sulphate
Glycopyrronium Bromide
Indacaterol Maleate
Tiotropium Bromide
Tobramycin
Beclomethasone Dipropionate
API List
Licensing
Knightpoint is seeking licensing agreements to combine the Mirai inhaler design with customers’ specific drug and formulation requirements. These are combination products, and we realize the device and drug need to be developed and optimized together as a system. We offer device design, prototyping, formulation assistance, and GMP testing, and we can tailor the system performance to meet your needs. Please contact us to hear more about our capabilities.